Sarah Pirrie
- Hepatology top 5%
- Cancer Research top 10%
- Breast Cancer Treatment Studies 10
- Oncology top 10%
- Bone health and treatments 4
-
- Prostate Cancer Treatment and Research 8
- Advanced Breast Cancer Therapies 6
- Renal cell carcinoma treatment 6
-
- Bladder and Urothelial Cancer Treatments 14
- Urinary and Genital Oncology Studies 7
-
- Radiopharmaceutical Chemistry and Applications 8
- Co-authors
- Nicholas D. JamesSyed A. HussainMabel TengPhilip J. JohnsonGillian PatmanShinji SatomuraTrevor F. CoxDiana Hull
- Cited by
- HepatologyCancer ResearchOncology
- Journals
- Journal of Clinical Oncology (11 papers)SHILAP Revista de lepidopterología (2 papers)Cancer Research (2 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Sarah Pirrie
42 papers receiving 780 citations
Peers
Comparison fields: 5 of 70
- Hepatology 200
- Cancer Research 255
- Oncology 265
- Pulmonary and Respiratory Medicine 238
- Epidemiology 179
Countries citing papers authored by Sarah Pirrie
This map shows the geographic impact of Sarah Pirrie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Pirrie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Pirrie more than expected).
Fields of papers citing papers by Sarah Pirrie
This network shows the impact of papers produced by Sarah Pirrie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Pirrie. The network helps show where Sarah Pirrie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sarah Pirrie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 25 | |
| 7 | 2022 | 5 | |
| 8 | 2022 | 2 | |
| 9 | 2022 | 3 | |
| 10 | 2021 | 1 | |
| 11 | 2021 | 38 | |
| 12 | 2020 | 25 | |
| 13 | 2019 | 125 | |
| 14 | 2018 | 10 | |
| 15 | 2018 | 21 | |
| 16 | 2015 | 35 | |
| 17 | 2014 | 8 | |
| 18 | 2014 | 20 | |
| 19 | 2013 | 232 | |
| 20 | 2008 | 5 |
About Sarah Pirrie
Sarah Pirrie is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 43 papers that have together received 792 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (14 papers), Breast Cancer Treatment Studies (10 papers), Radiopharmaceutical Chemistry and Applications (8 papers), Prostate Cancer Treatment and Research (8 papers), Urinary and Genital Oncology Studies (7 papers), Advanced Breast Cancer Therapies (6 papers), Renal cell carcinoma treatment (6 papers) and Bone health and treatments (4 papers). The work is most often cited by research in Hepatology (200 citations), Cancer Research (255 citations) and Oncology (265 citations). Sarah Pirrie has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Nicholas D. James, Syed A. Hussain, Mabel Teng, Philip J. Johnson, Gillian Patman, Shinji Satomura, Trevor F. Cox, Diana Hull, Daniel H. Palmer and Helen L. Reeves. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.